Toripalimab Plus Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer Reached Primary Endpoints in Phase III Clinical Study

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence